Clinical Trial Update: A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This document reports the completion/update of a Phase I study evaluating polyethylene glycol loxenatide in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Polyethylene Glycol Loxenatide (polyethylene glycol loxenatide)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED